Adverse effects and other safety aspects of the hepatitis C antivirals
- 1 May 2000
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 15 (s2) , E156-E163
- https://doi.org/10.1046/j.1440-1746.2000.02114.x
Abstract
Click on the article title to read more.Keywords
This publication has 73 references indexed in Scilit:
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centersJournal of Hepatology, 1997
- Interferon-α therapy May induce insulin autoantibody development in patients with chronic viral hepatitisDigestive Diseases and Sciences, 1996
- Adverse Effects of Interferon on the Cardiovascular System in Patients with Chronic Hepatitis C.Japanese Heart Journal, 1996
- Exacerbation of primary biliary cirrhosis during interferon-α2b therapy for chronic active hepatitis CDigestive Diseases and Sciences, 1995
- Assessment of interferon cardiotoxicity with quantitative radionuclide angiocardiographyEuropean Journal of Clinical Investigation, 1995
- Hazards of interferon treatment in patients with autoimmune chronic active hepatitisJournal of Hepatology, 1994
- Systemic lupus erythematosus in a child receiving long-term interferon therapyThe Journal of Pediatrics, 1992
- Increase in triglicerides during α -interferon treatment of chronic viral hepatitisJournal of Hepatology, 1992
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989